Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL139352 | 0.91 | NPC1 (0.34) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| Hydrochloric Acid SCHEMBL141834 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL10318280 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL674569 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL5081833 | 0.79 | NPC1 (0.32) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| Hydrochloric Acid SCHEMBL144294 | 0.79 | KCNK9 (0.30) | — | |
| Hydrochloric Acid SCHEMBL10320714 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL10318871 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL1664677 | 0.79 | NPC1 (0.30) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| Hydrochloric Acid SCHEMBL139153 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059135-A1 | COPOLYMER OF OLEFIN AND CONJUGATED DIENE, AND PROCESS FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20110196103-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | MITSUI CHEMICALS, INC. (US) | 2011-08-11 | — | — | US | disclosed |
| US-7767313-B2 | Polypropylene composite film comprising a metallocene-catalyzed propylene/1-butene random copolymer | MITSUI CHEMICALS, INC. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-7737239-B2 | Propylene copolymer, polypropylene composition and uses thereof, transition metal compound and olefin polymerization catalyst | MITSUI CHEMICALS, INC. (JP) | 2010-06-15 | — | — | US | disclosed |
| US-7728078-B2 | Blend of a polypropylene and a elastomeric copolymer of 60-90 mol % propylene units and 10- 40 mol % of 1-butene units; sheets and films with excellent flexibility and impact resistance as well as sufficient heat resistance and low-temperature heat-sealability | MITSUI CHEMICALS, INC. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-7678934-B2 | Propylene copolymer, polypropylene composition and uses thereof, transition metal compound and olefin polymerization catalyst | MITSUI CHEMICALS, INC. (JP) | 2010-03-16 | — | — | US | disclosed |
| US-20090043050-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | IKENAGA SHIGENOBU | 2009-02-12 | — | — | US | disclosed |
| US-7488789-B2 | Propylene copolymer, polypropylene composition, and uses thereof, transition metal compounds and catalyst for olefin polymerization | MITSUI CHEMICALS, INC. (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20080312461-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | IKENAGA SHIGENOBU | 2008-12-18 | — | — | US | disclosed |
| US-20080306234-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | IKENAGA SHIGENOBU | 2008-12-11 | — | — | US | disclosed |
| US-20080306219-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | IKENAGA SHIGENOBU | 2008-12-11 | — | — | US | disclosed |
| US-20080292896-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | IKENAGA SHIGENOBU | 2008-11-27 | — | — | US | disclosed |
| US-20060276607-A1 | Propylene copolymer, polypropylene composition, and uses thereof, transition metal compounds and catalyst for olefin polymerization | MITSUI CHEMICALS, INC. (JP) | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312461-A1 | PROPYLENE COPOLYMER, POLYPROPYLENE COMPOSITION AND USES THEREOF, TRANSITION METAL COMPOUND AND OLEFIN POLYMERIZATION CATALYST | PPIA, PPOX, PTGES2 | NPC1 3727/4885ALDH1A1 3243/4885PLA2G1B 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.